SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-24-002369
Accepted
2024-08-05 00:15:03
Documents
1
Effectiveness Date
2024-08-02
Registration Form
S-4

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 588
  Complete submission text file 9999999995-24-002369.txt   1753
Mailing Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540 609-649-9272
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: EFFECT | Act: 33 | File No.: 333-280536 | Film No.: 241172988
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)